70 related articles for article (PubMed ID: 12593662)
1. Synthesis and flow cytometric evaluation of novel 1,2,3,4-tetrahydroisoquinoline conformationally constrained analogues of nitrobenzylmercaptopurine riboside (NBMPR) designed for probing its conformation when bound to the es nucleoside transporter.
Zhu Z; Furr J; Buolamwini JK
J Med Chem; 2003 Feb; 46(5):831-7. PubMed ID: 12593662
[TBL] [Abstract][Full Text] [Related]
2. Constrained NBMPR analogue synthesis, pharmacophore mapping and 3D-QSAR modeling of equilibrative nucleoside transporter 1 (ENT1) inhibitory activity.
Zhu Z; Buolamwini JK
Bioorg Med Chem; 2008 Apr; 16(7):3848-65. PubMed ID: 18289860
[TBL] [Abstract][Full Text] [Related]
3. Novel C2-purine position analogs of nitrobenzylmercaptopurine riboside as human equilibrative nucleoside transporter 1 inhibitors.
Gupte A; Buolamwini JK
Bioorg Med Chem; 2007 Dec; 15(24):7726-37. PubMed ID: 17881236
[TBL] [Abstract][Full Text] [Related]
4. Novel halogenated nitrobenzylthioinosine analogs as es nucleoside transporter inhibitors.
Gupte A; Buolamwini JK
Bioorg Med Chem Lett; 2004 May; 14(9):2257-60. PubMed ID: 15081020
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric quantitation of nucleoside transporter sites on human leukemic cells.
Jamieson GP; Brocklebank AM; Snook MB; Sawyer WH; Buolamwini JK; Paterson AR; Wiley JS
Cytometry; 1993; 14(1):32-8. PubMed ID: 8432200
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological analysis and molecular cloning of the canine equilibrative nucleoside transporter 1.
Hammond JR; Stolk M; Archer RG; McConnell K
Eur J Pharmacol; 2004 Apr; 491(1):9-19. PubMed ID: 15102528
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, flow cytometric evaluation, and identification of highly potent dipyridamole analogues as equilibrative nucleoside transporter 1 inhibitors.
Lin W; Buolamwini JK
J Med Chem; 2007 Aug; 50(16):3906-20. PubMed ID: 17636949
[TBL] [Abstract][Full Text] [Related]
8. Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q).
Vickers MF; Mani RS; Sundaram M; Hogue DL; Young JD; Baldwin SA; Cass CE
Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):21-32. PubMed ID: 10085223
[TBL] [Abstract][Full Text] [Related]
9. A new fluorescent probe for the equilibrative inhibitor-sensitive nucleoside transporter. 5'-S-(2-aminoethyl)-N6-(4-nitrobenzyl)-5'-thioadenosine (SAENTA)-chi 2-fluorescein.
Wiley JS; Brocklebank AM; Snook MB; Jamieson GP; Sawyer WH; Craik JD; Cass CE; Robins MJ; McAdam DP; Paterson AR
Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):667-72. PubMed ID: 1996965
[TBL] [Abstract][Full Text] [Related]
10. Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1.
Endres CJ; Sengupta DJ; Unadkat JD
Biochem J; 2004 May; 380(Pt 1):131-7. PubMed ID: 14759222
[TBL] [Abstract][Full Text] [Related]
11. Cysteine residues in the transmembrane (TM) 9 to TM11 region of the human equilibrative nucleoside transporter subtype 1 play an important role in inhibitor binding and translocation function.
Park JS; Hammond JR
Mol Pharmacol; 2012 Nov; 82(5):784-94. PubMed ID: 22837314
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and evaluation of 2-diethanolamino-4,8-diheptamethyleneimino-2-(N-aminoethyl-N-ethanolamino)-6-(N,N-diethanolamino)pyrimido[5,4-d]pyrimidine-fluorescein conjugate (8MDP-fluor), as a novel equilibrative nucleoside transporter probe.
Lin W; Buolamwini JK
Bioconjug Chem; 2011 Jun; 22(6):1221-7. PubMed ID: 21539390
[TBL] [Abstract][Full Text] [Related]
13. CoMFA and CoMSIA 3D-QSAR studies on S(6)-(4-nitrobenzyl)mercaptopurine riboside (NBMPR) analogs as inhibitors of human equilibrative nucleoside transporter 1 (hENT1).
Gupte A; Buolamwini JK
Bioorg Med Chem Lett; 2009 Jan; 19(2):314-8. PubMed ID: 19091561
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and evaluation of 5'-S-aminoethyl-N(6)- azidobenzyl-5'-thioadenosine biotin conjugate: a bifunctional photoaffinity probe for the es nucleoside transporter.
Addo JK; Buolamwini JK
Bioconjug Chem; 2004; 15(3):536-40. PubMed ID: 15149181
[TBL] [Abstract][Full Text] [Related]
15. Nucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cells.
Archer RG; Pitelka V; Hammond JR
Br J Pharmacol; 2004 Sep; 143(1):202-14. PubMed ID: 15289294
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of acute leukemia cells to cytarabine is a correlate of cellular es nucleoside transporter site content measured by flow cytometry with SAENTA-fluorescein.
Gati WP; Paterson AR; Larratt LM; Turner AR; Belch AR
Blood; 1997 Jul; 90(1):346-53. PubMed ID: 9207471
[TBL] [Abstract][Full Text] [Related]
17. Interaction of the novel adenosine uptake inhibitor 3-[1-(6,7-diethoxy-2-morpholinoquinazolin-4-yl)piperidin-4-yl]-1,6-dimethyl-2,4(1H,3H)-quinazolinedione hydrochloride (KF24345) with the es and ei subtypes of equilibrative nucleoside transporters.
Hammond JR; Archer RG
J Pharmacol Exp Ther; 2004 Mar; 308(3):1083-93. PubMed ID: 14634039
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the equilibrative nucleoside transporter by inhibitors of DNA synthesis.
Pressacco J; Wiley JS; Jamieson GP; Erlichman C; Hedley DW
Br J Cancer; 1995 Oct; 72(4):939-42. PubMed ID: 7547244
[TBL] [Abstract][Full Text] [Related]
19. Kinetic analysis of ligand binding to the Ehrlich cell nucleoside transporter: pharmacological characterization of allosteric interactions with the [3H]nitrobenzylthioinosine binding site.
Hammond JR
Mol Pharmacol; 1991 Jun; 39(6):771-9. PubMed ID: 2051991
[TBL] [Abstract][Full Text] [Related]
20. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
SenGupta DJ; Unadkat JD
Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
